Table 1.
Comparison of phenotypic antimicrobial susceptibility testing and genome-derived resistance prediction for non-typhoidal Salmonella enterica (n = 3491).
| Antimicrobial | Phenotype: susceptible |
Phenotype: resistant |
Sensitivity (%) | Specificity (%) | ||
|---|---|---|---|---|---|---|
| Genotype: resistant | Genotype: susceptible | Genotype: resistant | Genotype: susceptible | |||
| Ampicillin | 1 | 2742 | 747 | 1 | 99.87 | 99.96 |
| Temocillin | 0 | 3490 | 0 | 1 | 0 | 100 |
| Cefoxitin | 0 | 3471 | 19 | 1 | 95.0 | 100 |
| Cefotaxime | 0 | 3434 | 57 | 0 | 100 | 100 |
| Ceftazidime | 0 | 3444 | 47 | 0 | 100 | 100 |
| Cefpirome | 0 | 3444 | 47 | 0 | 100 | 100 |
| Ertapenem | 0 | 3481 | 10 | 0 | 100 | 100 |
| Chloramphenicol | 4 | 3284 | 201 | 2 | 99.01 | 99.88 |
| Gentamicin | 1 | 3351 | 138 | 1 | 99.28 | 99.97 |
| Streptomycin | 51 | 2821 | 613 | 8 | 98.71 | 98.22 |
| Tobramycin | 2 | 3392 | 97 | 0 | 100 | 99.94 |
| Sulphonamides | 2 | 2661 | 828 | 0 | 100 | 99.92 |
| Tetracycline | 6 | 2568 | 917 | 0 | 100 | 99.77 |
| Trimethoprim | 1 | 3185 | 301 | 4 | 98.69 | 99.97 |
| Ciprofloxacin | 1 | 3352 | 137 | 1 | 99.28 | 99.97 |
Values shown designate the number of isolates. For ciprofloxacin only isolates with a MIC > 0.5 mg/L are shown.